China NMPA Product Recall - High-frequency electrosurgical system accessories

The National Medical Products Administration (NMPA) has announced a Class II voluntary recall initiated by Covidien LLC, reported by Covidien Medical Devices International Trading (Shanghai) Co., Ltd. The recall, published on February 19, 2020, pertains to accessories for Covidien's high-frequency electrosurgical systems. The critical issue identified is the potential for incomplete sealing in the sterile packaging of specific models and batches of these products. This packaging defect presents a significant concern as it could elevate the risk of infection for patients if compromised products are used during medical procedures.

In response to this manufacturing concern, Covidien LLC has proactively taken action to retrieve the affected accessories from the market. The regulatory oversight for this recall falls under the NMPA, which categorizes it as a Class II recall, indicating a situation where the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. Details concerning the exact product models, specifications, and batch numbers subject to this recall are provided in an accompanying "Medical Device Recall Event Report Form," enabling healthcare providers and distributors to identify and manage the impacted inventory effectively. This action underscores the company's commitment to patient safety and adherence to medical device quality standards under the NMPA's framework.